Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
Holding CDT?
Track your performance easily
CDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.08 - $7.83
Previous Close$0.09
Volume573.34M
Average Volume (3M)12.87M
Market Cap
$9.47M
Enterprise Value$10.33M
Total Cash (Recent Filing)$414.00K
Total Debt (Recent Filing)$1.27M
Price to Earnings (P/E)―
Beta0.76
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding102,847,973
10 Day Avg. Volume7,027,364
30 Day Avg. Volume12,870,654
Standard Deviation0.40
R-Squared0.07
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-1.85
Price to Sales (P/S)2.10
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda4.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Conduit Pharmaceuticals News
PremiumCompany Announcements
Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update
PremiumCompany Announcements
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements
Ownership Overview
9.75% Insiders
0.78% Mutual Funds
0.08% Other Institutional Investors
88.75% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CDT FAQ
What was Conduit Pharmaceuticals’s price range in the past 12 months?
Conduit Pharmaceuticals lowest stock price was $0.08 and its highest was $7.83 in the past 12 months.
What is Conduit Pharmaceuticals’s market cap?
Currently, no data Available
When is Conduit Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Conduit Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Conduit Pharmaceuticals overvalued?
According to Wall Street analysts Conduit Pharmaceuticals’s price is currently Overvalued.
Does Conduit Pharmaceuticals pay dividends?
Conduit Pharmaceuticals does not currently pay dividends.
What is Conduit Pharmaceuticals’s EPS estimate?
Conduit Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Conduit Pharmaceuticals have?
Conduit Pharmaceuticals has 102,847,980 shares outstanding.
What happened to Conduit Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Conduit Pharmaceuticals?
Among the largest hedge funds holding Conduit Pharmaceuticals’s share is Saba Capital Management. It holds Conduit Pharmaceuticals’s shares valued at N/A.
---
Conduit Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.0%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.81%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-75.10%
Trailing 12-Months
Company Description
Conduit Pharmaceuticals
Murphy Canyon Acquisition Corp is a blank check company.
---
Technical Analysis
Corbus Pharmaceuticals
―
Ovid Therapeutics
―
Aurinia Pharmaceuticals
―
Bioxcel Therapeutics
―
---